Cerevance Announces Presentations at AD/PD™ 2023
Positive CVN424 Phase 2 data for Parkinson’s disease to be presented Presentation of NETSseq platform’s ability to reveal novel targets to inform CNS drug...
Source: globenewswire.com
📰 Facilitates Identification News
Facilitates Identification News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Facilitates Identification. Real-time updates on events, politics, business and more.